High adherers, n (%) | Slow decliners, n (%) | Rapid decliners, n (%) | |
---|---|---|---|
Total | 2,465 (57) | 1,587 (36) | 301 (6.9) |
Age at diagnosis | |||
< 40 | 359 (15) | 261 (16) | 54 (18) |
40–49 | 1,548 (63) | 975 (61) | 173 (57) |
50–55 | 558 (23) | 351 (22) | 74 (25) |
Charlson Comorbidity Index score | |||
None | 2,234 (91) | 1,382 (87) | 259 (86) |
One or higher | 231 (9.4) | 205 (13) | 42 (14) |
Stage at diagnosisa | |||
Stage I | 549 (22) | 465 (29) | 106 (35) |
Stage II | 1,398 (57) | 837 (53) | 147 (49) |
Stage III | 518 (21) | 285 (18) | 48 (16) |
Positive lymph nodesa | |||
None | 832 (34) | 637 (40) | 147 (49) |
One | 658 (27) | 391 (25) | 60 (20) |
Two or more | 975 (40) | 559 (35) | 94 (31) |
Histological gradea | |||
I | 500 (20) | 343 (22) | 68 (23) |
II | 1,289 (52) | 819 (52) | 163 (54) |
III | 524 (21) | 310 (20) | 56 (19) |
Unknown/not graded | 135 (5.5) | 101 (6.4) | 13 (4.3) |
Tumor sizea, b | |||
< 2 cm | 1,354 (55) | 969 (61) | 189 (63) |
> 2-5 cm | 1,019 (41) | < 580 | < 115 |
> 5 cm | 92 (3.7) | < 55 | < 5 |
HER2 status | |||
HER2 negative | 1,517 (62) | 1,030 (65) | 189 (63) |
HER2 positive | 301 (12) | 227 (14) | 51 (17) |
Unknown/not measured | 647 (26) | 330 (21) | 61 (20) |
Treated with chemotherapy | |||
Yes | 2,354 (96) | 1,362 (86) | 247 (82) |
No | 111 (4.5) | 225 (14) | 54 (18) |
Surgery type and radiotherapy | |||
Mastectomy without radiotherapy | 364 (15) | 215 (14) | 49 (16) |
Mastectomy and radiotherapy | 788 (32) | 433 (27) | 79 (26) |
Lumpectomy | 1,313 (53) | 939 (59) | 173 (57) |